Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-3281 in Healthy and Hepatitis C Infected Male Participants (MK-3281-002)
Clinical trial NCT00635804 · COMPLETED
Trial details
- NCT number
- NCT00635804
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-19
- Primary completion
- 2009-12-22
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.